The NIAID Centralized Sequencing Program provides clinical research genomic services at the NIH Clinical Center. The goal of the program is to raise the standard for routine clinical care and facilitating research. Any NIAID participant is eligible to receive genome sequencing and associated services through this protocol.
We have partnered with dozens of NIAID and NIH investigators, as well as the Children's National Health System, to enroll thousands of participants: this includes participants who are suspected to have a Mendelian disease, as well as cohorts with more complex disease etiologies.
Learn more about the NIAID Centralized Sequencing Program.